CT HB06588

Individual health insurance policies delivered or renewed in Connecticut on or after January 1, 2022 cannot require prescribers to dispense larger supplies of psychotropic drugs than clinically appropriate or charge higher out-of-pocket costs for supplies smaller than 90 days.

Group health insurance policies delivered or renewed in Connecticut on or after January 1, 2022 are subject to the same restrictions on psychotropic drug supply requirements and proportional cost-sharing as individual policies.

State mental health care benefits cannot use formularies or other means to limit access to the most effective psychotropic drugs with the least adverse side effects, or require prescribers to dispense supplies larger than clinically appropriate.

Differential copayments among pharmaceutical treatments and utilization review remain permitted under the law.

A task force is established to study methods for encouraging mental health care providers to participate in insurance provider networks, with a report due to the General Assembly by January 1, 2022.